Cytonus Therapeutics

company

About

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$300K
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Cytonus Therapeutics is a biotech company combining AI-driven drug discovery with a Cargocyte, a synthetic biology approach towards drug-delivery. Cytonus is on a mission to treat immune related disorders with precision delivery and in vivo production of first in class therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$1.47M
Cytonus Therapeutics has raised a total of $1.47M in funding over 2 rounds. Their latest funding was raised on Jul 1, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2021 Grant $300K 1 Detail
Mar 1, 2021 Grant $450K 1 Detail
Nov 1, 2020 Grant $400K 1 Detail
Oct 1, 2020 Grant 1 Detail
Apr 1, 2020 Grant $325K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cytonus Therapeutics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant